Paper40740948
Reevaluating anticoagulation therapy for sepsis-associated disseminated intravascular coagulation based on endothelial glycocalyx shedding quantification: a single-center, retrospective, observational pilot study.
Suzuki K and 7 others. Front Med (Lausanne), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Reevaluating anticoagulation therapy for sepsis-associated disseminated intravascular coagulation based on endothelial glycocalyx shedding quantification: a single-center, retrospective, observational pilot study. Papers, record 40740948. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40740948
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Reevaluating anticoagulation therapy for sepsis-associated disseminated intravascular coagulation based on endothelial glycocalyx shedding quantification: a single-center, retrospective, observational pilot study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38282162 | Recombinant antithrombin attenuates acute kidney injury associated with rhabdomyolysis: an in vivo animal study. | Intensive Care Med Exp | 2024 | https://conductscience.org/library/papers/38282162 | PubMed |
| 2 | 16521260 | A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. | Crit Care Med | 2006 | https://conductscience.org/library/papers/16521260 | PubMed |
| 3 | 35480580 | Prognostic Value of Syndecan-1 in the Prediction of Sepsis-Related Complications and Mortality: A Meta-Analysis. | Front Public Health | 2022 | https://conductscience.org/library/papers/35480580 | PubMed |
| 4 | 25023776 | Unfractionated heparin suppresses lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human microvascular endothelial cells by blocking Krüppel-like factor 5 and nuclear factor-κB pathway. | Immunobiology | 2014 | https://conductscience.org/library/papers/25023776 | PubMed |
| 5 | 34599691 | Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/34599691 | PubMed |
| 6 | 15550023 | Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. | J Thromb Haemost | 2004 | https://conductscience.org/library/papers/15550023 | PubMed |
| 7 | 36353180 | Recombinant thrombomodulin may protect cardiac capillary endothelial glycocalyx through promoting Glypican-1 expression under experimental endotoxemia. | Heliyon | 2022 | https://conductscience.org/library/papers/36353180 | PubMed |
| 8 | 39681545 | Dynamic changes and prognosis value of plasma syndecan-1 and different microcirculatory parameters in sepsis: A prospective observational study. | World J Surg | 2025 | https://conductscience.org/library/papers/39681545 | PubMed |
| 9 | 12168569 | The anti-inflammatory actions of antithrombin--a review. | Acta Med Austriaca | 2002 | https://conductscience.org/library/papers/12168569 | PubMed |
| 10 | 36639780 | The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update? | Crit Care | 2023 | https://conductscience.org/library/papers/36639780 | PubMed |
| 11 | 33504351 | Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury. | Thromb J | 2021 | https://conductscience.org/library/papers/33504351 | PubMed |
| 12 | 36802946 | Effect of Anticoagulant Versus Non-Anticoagulant Therapy on Mortality of Sepsis-Induced Disseminated Intravascular Coagulation: A Systematic Review and Meta-Analysis. | Clin Appl Thromb Hemost | 2023 | https://conductscience.org/library/papers/36802946 | PubMed |
| 13 | 34116023 | Recombinant Antithrombin Attenuates Acute Respiratory Distress Syndrome in Experimental Endotoxemia. | Am J Pathol | 2021 | https://conductscience.org/library/papers/34116023 | PubMed |
| 14 | 37256226 | Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37256226 | PubMed |
| 15 | 34484801 | The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). | Acute Med Surg | 2021 | https://conductscience.org/library/papers/34484801 | PubMed |
| 16 | 26903338 | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | JAMA | 2016 | https://conductscience.org/library/papers/26903338 | PubMed |
| 17 | 28963294 | New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. | BMJ Open | 2017 | https://conductscience.org/library/papers/28963294 | PubMed |
| 18 | 33893369 | Serum syndecan-1 reflects organ dysfunction in critically ill patients. | Sci Rep | 2021 | https://conductscience.org/library/papers/33893369 | PubMed |
| 19 | 29327601 | Syndecan-1 as a biomarker for sepsis survival after major abdominal surgery. | Biomark Med | 2018 | https://conductscience.org/library/papers/29327601 | PubMed |
| 20 | 26676884 | Antithrombin: anti-inflammatory properties and clinical applications. | Thromb Haemost | 2016 | https://conductscience.org/library/papers/26676884 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909518 | Promising therapeutic interventions for preserving endothelial glycocalyx integrity in sepsis: a systematic review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42909518 | PubMed |
| 41331689 | Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials. | Thromb J | 2025 | https://conductscience.org/library/papers/41331689 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 | NCBI Gene |
| SDC1 | 6382 | PubTator's text mining | https://conductscience.org/library/genes/6382 | NCBI Gene |
| SERPINC1 | 462 | PubTator's text mining | https://conductscience.org/library/genes/462 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
| THBD | 7056 | PubTator's text mining | https://conductscience.org/library/genes/7056 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40740948
GET https://conductscience.org/api/papers/v1/40740948/references?page=2